NeuroFlow, Inc.
AI-powered behavioral health platform with EHR interoperability, natural language processing for crisis detection, and personalized patient engagement tools
- Sector
- Digital health
- Headquarters
- PHILADELPHIA, PA
- Founded
- 2017
- Latest Form D
- $25.5M, Oct 2022
- Total capital
- $47.3M
- Federal grants
- $1.9M
- 5 awards · 2018–2023
- Rank in peer group#3 of 16
- Private capital raised
- $45.4M
- 5 Form D · last Oct 2022
- 48 months since last filing
- Federal contracts
- None on recordNo federal contract awards found.
- Granted patents
- None on recordNo USPTO grants. Applications publish after 18 months.
Capital timeline
Latest events
- Federal grantDefense · Phase I · Enhancing Resiliency And Wellness In Military Healthcare Settings Through Digital Measurement-based Care$104K
- Private capital raisedForm D · SEC · 5th filing$25.5M
- Private capital raisedForm D · SEC · 4th filing$11M
- Federal grantNSF · Phase II · SBIR Phase II: Implementation of a Digital Health Platform to Enable Behavioral Health Integration in Multiple Care Settings$1.4M
- Federal grantDefense · Phase I · Building resiliency, promoting readiness, and augmenting population health management in a military care setting$48K
- Private capital raisedForm D · SEC · 3rd filing$6.9M
- Federal grantDefense · Phase I · Building resiliency, promoting readiness, and augmenting behavioral health treatment within an integrated care setting$48K
- Private capital raisedForm D · SEC · 2nd filing$1.1M
- Private capital raisedForm D · SEC · 1st filing$906K
Show 1 earlier federal award
- Federal grantNSF · Phase I · STTR Phase I: Implementation of a Biometric Data Software Platform to Augment Mental Health Treatment$225K
Node area is scaled to amount. Form D reports securities sold, which can differ from an announced round; filings are numbered in the order they were made.
Standing among 16 peers
Line = medianDigital health · Platform
- Federal grants#3 · top 19%
Cumulative measures favor older companies. Rankings describe position today, not outcome. Below the median, ranks show as a band rather than a number.
Founders and team
Researcher links verified by same-company patents and grants- Adam PardesResearcherExecutive Officer, DirectorLinked by $1.7M in grants as PI
- Alan Wayne TamarelliDirectorNamed in SEC Form D filings
- Christopher MolaroExecutive Officer, DirectorNamed in SEC Form D filings
- Enrico Wayne PicazzoDirectorNamed in SEC Form D filings
- Mark Wayne GoldsteinDirectorNamed in SEC Form D filings
- Mark Wayne McAdooDirectorNamed in SEC Form D filings
Show all 7 people
- Mark Wayne MillerDirectorNamed in SEC Form D filings
What it has protected
No granted patents are on record.
USPTO usually publishes applications 18 months after filing, so recent applications may not be visible yet. Patents assigned under a different entity name won’t match.
Checked: USPTO granted patents and published applications · Oct 23, 2026
Related companies, and why
- NEUROFLOW INCShares a founder: Adam Pardes
- DASION CORPORATIONSimilar federal contract value in Digital health · null in contracts
- K Health, Inc.Similar federal contract value in Digital health · null in contracts
- MEDPLEX SYSTEMS, INCSimilar federal contract value in Digital health · null in contracts
- Lateral Care Inc.Similar federal contract value in Digital health · null in contracts
- DIGITAL COGNITION TECHNOLOGIES, INC.Similar federal contract value in Digital health · null in contracts
Regulatory activity · Digital health
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.
Sources
Federal grants from SBIR/STTR, NIH, NSF and DoD records. Federal contracts from USAspending.gov. Private capital from SEC Form D. Patents from USPTO. Publications from OpenAlex. Regulatory activity from the Federal Register. Press matched on company name.
How to read this page
Figures show associations in public records, not causes or predictions. Nothing here is investment advice. An em-dash means no record was found under this company's name, not that none exists.
Data freshness
SEC Form D filings through . SBIR and STTR awards through .